Recent AMED Stock Price | AMED Stock Predictions | |
$90.78 | +11.13% |
$100.88 |
Recent AMED Analyst Ratings Breakdown, Making AMED Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 2 | 2 | 2 | 2 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 8 | 8 | 8 | 8 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.55 | 2.55 | 2.55 | 2.55 |
For the AMED stock predictions from the analysts covering Amedisys, Inc., we have collected all of the individual AMED stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 8 different analysts covering AMED (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since AMED stock predictions may vary widely, another useful metric to consider is the median AMED stock prediction, which represents the price at which half of the analysts
made AMED stock predictions that were higher and half made AMED stock predictions that were lower. This makes for a different take on the AMED stock predictions out there, as compared to average or mean.
And that median across all the individual AMED stock predictions was: $101.0 as of 2024-04-19.
The very highest of the AMED stock predictions for one year price target was $101.0, while the very lowest of the AMED stock predictions in the analyst group was
$100.0 (with a standard deviation of $0.353). Get the latest Zacks research report on AMED — FREE
Find out: AMED next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
DRH Stock Predictions
RPRX Stock Predictions
CHKP Stock Predictions
NPTN Stock Predictions
UFS Stock Predictions
DPZ Stock Predictions
TESS Stock Predictions
GLOG Stock Predictions
PVBC Stock Predictions
|
|
Hold (2.45 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |